13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Combination approaches to combat multidrug-resistant bacteria.

      Trends in Biotechnology
      Adjuvants, Pharmaceutic, therapeutic use, Anti-Bacterial Agents, Bacterial Infections, drug therapy, microbiology, Drug Resistance, Multiple, Bacterial, Drug Therapy, Combination, methods, Humans

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The increasing prevalence of infections caused by multidrug-resistant bacteria is a global health problem that has been exacerbated by the dearth of novel classes of antibiotics entering the clinic over the past 40 years. Herein, we describe recent developments toward combination therapies for the treatment of multidrug-resistant bacterial infections. These efforts include antibiotic-antibiotic combinations, and the development of adjuvants that either directly target resistance mechanisms such as the inhibition of β-lactamase enzymes, or indirectly target resistance by interfering with bacterial signaling pathways such as two-component systems (TCSs). We also discuss screening of libraries of previously approved drugs to identify nonobvious antimicrobial adjuvants. Copyright © 2012 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Journal
          23333434
          3594660
          10.1016/j.tibtech.2012.12.006

          Chemistry
          Adjuvants, Pharmaceutic,therapeutic use,Anti-Bacterial Agents,Bacterial Infections,drug therapy,microbiology,Drug Resistance, Multiple, Bacterial,Drug Therapy, Combination,methods,Humans

          Comments

          Comment on this article